Followers | 353 |
Posts | 13825 |
Boards Moderated | 5 |
Alias Born | 09/27/2010 |
Tuesday, April 14, 2015 8:30:09 PM
There is so much more to ARTH than meets the eye. Full disclosure I do not own and have never bought it (yet).
Their product that stops bleeding was an accidental find while doing R&D for what their main goal is. Consider the possibilities of being bought out by a big bio tech/pharma company for several hundred million at a minimum based just off the accidental product.. tip of their iceburg if you will.
I'm assuming you know the CEO's full history. Considering what he used to do (including running the worlds 2nd largest bio-tech fund for Putnam Investments ($4billion bio-tech fund)), why would he give up sooo many years of his life devoting it to a company this size.
PLSB I'll get some DD too you in a few weeks (earlier if possible - I know the company in and out more or less). I'm just slammed busy for another few weeks. What's easy to say now is that anything sub .20 is great, sell half mid/low .30's and stack free shares. It's not going lower. It's bottomed here for months and held and I've watched it trade for months. It appears nowhere to go but up.
ENCR I'll add it to my watch list in the morning and start some DD there.
Looking 1-2-3 years out if we're going that route, VYCO, ESES, ADMP, and quite possibly ONCS (a spin-off from INO) all have my vote. ESES won't go lower than where it is imo. VYCO anything sub 1.60 appears a good scoop up. ADMP mid 3's if possible. PLSB and ARTH anything sub .20.
giving you a member mark. cheers
Stay very disciplined and consistent.
Find what works for you and stick with it.
Identify support/resistance ranges to buy and sell.
Invest in the fundamentals, trade the technicals.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM